National and Kapodistrian University of Athens
Μελέτη της επίδρασης φαρμακολογικών παραγόντων στην ανάπτυξη του κρανίου και των οδόντων θηλαστικών
Abstract
dc:descriptionThe organogenesis of head, jaws and teeth is coordinated by many intrinsic growth and morphogenetic factors. Retinoic acid (RA) and bone morphogenetic protein 4 (BMP4) possess a prominent place among them. RA (oxidized form of vitamin A) plays a primary role in the expression of Hox genes, which control and regulate organ morphogenesis at their appropriate position along the anterior/posterior axis of the developing embryo. BMP4 participates actively to cranial bone morphogenesis and in the differentiation of odontoblasts and smaltoblasts, whereas it induces the differentiation of tooth pulp mesenchymal cells into odontoblasts, a fact which might be used profitably in clinical applications for therapeutic purposes. In most embryonic animal models the action of several morphogenetic factors depends on various other factors as well as on their antagonists. For the purposes of the present assay it is worth noting that RA and BMP4 are mutually interactive: BMP4 attenuates signalling of the RA pathway, whereas, inhibition of RA synthesis diminishes BMP4 expression. Disturbances in their interaction might lead to morphogenetic abnormalities, which in their turn would indicate whether an exogenously administered substance is harmful for the embryos. This research program was motivated by the fact that, inhibitors of RA and antagonists of BMP4 might frequently contact human tissues (voluntary and involuntary, as well as consciously and inconciously) with unanticipated, adverse effects. A distal goal of similar studies is their contribution in the prevention of side –effects and in clinical applications. In order to achieve our purposes we have used common white mice (balb-c Mus musculus) being at their 9th day of gestation. The animals received a single intra-abdominal injection of 3 μL citral/gbw or 50 μg αnti-BMP4 antibody. We are aware that results from animal studies cannot be directly translated to humans, however, in the case of mouse there is a lot of evidence advocating their use as models for human affairs. The study was performed on newborns within 5 hours after birth. Our results were evaluated by the following methods: (a) Macroscopically, including body weight, length of body, tail and limbs. Presence, number and position of various organs (eyes, ears, nose, whiskers, digits) was inspected. (b) Stereoscopically, after Alcian blue and alizarin red S double staining for mucopolysaccharides and bone, respectively. (c) Microscopically, after (c1) histological staining of paraffin section (c2) immunohistochemical detection of apoptosis (c3) immunohistochemical detection of BMP4 distribution (c4) scanning electron microscopy During the course of the present study, a retinoic acid inhibitor (citral) and a BMP4 neutralizer (anti-BMP4 antibody) were intra-abdominally injected into pregnant mice. Macroscopical examination did not reveal any difference or external variations/abnormalities between control and experimental newborns. This result might mean that the quantities and the mode of application of those substances do not cause external variations. This result might well be due to the action of other, similar factors. The simplest explanation is that the free quantities of RA and BMP4 are sufficient to produce the normal external phenotype. However, double staining of cartilage and bone revealed retardation in osteogenesis in experimental animals. Our results are in full agreement with similar studies concerning action of BMP4 and their antagonists in developmental processes, such as neurulation, chondrogenesis and head morphogenesis. The introduction into the developing embryo of a quantity of BMP4 antagonist diminishes part of the free BMP4 resulting in the expression of survival factors (e.g., FGF8) a fact which elongates the life span of mesenchymal cells and retards their differentiation into osteoblasts. In addition, the presence of citral inhibits the action of retiladehyde dehydrogenase, diminishes RA quantity resulting in diminution of expression of the osteocalcin gene, a fact which disturbs osteogenesis. In agreement with the above, comparison of histological slides between experimental and control animals showed that, RA insufficiency (caused by citral) and presence of anti-BMP4 antibody (restriction of free BMP4 molecules) causes some minor deviations from the normal phenotype and/or in the time of display of the normal phenotype. Reports from other laboratories support the notion that RA insufficiency diminishes Shh gene expression, a fact which affects Bmps gene expression, so that the differentiation of mesenchymal cells into osteoblasts/odontoblasts is inhibited or retarded. The physiological phenotype of the experimental animals grown to adulthood indicates that the two substances tested at these comparatively high quantities are quite safe, at least for the species studied (Mus musculus). However, it must be emphatically stressed that the quantity of a substance, that externally administered causes from mild and reparable microvariations from the normal phenotype to serious morphogenetic abnormalities and teratogenesis differs significantly from species to species. Briefly, the results of my PhD Thesis indicate that, in vivo administration of citral (i.e., a process which restricts the synthesis of the needed quantity of RA) disturbs (usually restriction/retardation) chondrogenesis and osteogenesis in head skeletal elements. After birth, apoptosis is not detected at both experimental and control animals. In vivo administration of anti-BMP4 antibody results in a transient disturbance in the «physiological» course of odontoblast differentiation and in the production of pre-dentin, whereas, the retardation in osteogenesis includes alveolar bones too.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koussoulakou, Despina
- Κουσουλάκου, Δέσποινα
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27874